glp 1 development history A timeline of GLP- discovery and clinical development. Created in Evolution of GLP‐1 Receptor Agonists

As of August 2025, nearly 12% of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64

Thomas CM, Hong T, van Pijkeren JP, Hemarajata P, Trinh DV, Hu W, et al

Above 3%, many users experience scalp redness, irritation, or discomfort

Hormonal Recovery and System Reset While traditional SERM-based PCT (e.g., Clomid, Nolvadex) may not be necessary after HGH or IGF-1 LR3 alone, users should still support: Liver and metabolic health Insulin sensitivity restoration Endogenous IGF-1 balance Testosterone production (if steroids were included) Prolonged use of IGF-1 analogs may lead to negative feedback on GH/IGF axis and necessitate time off or tapering for hormonal normalization. Baxter, R

503B Outsourcing Facilities These are FDA-registered facilities that can manufacture larger batches of compounded medications and ship across state lines